The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasai, M.
Right arrow Articles by Seya, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasai, M.
Right arrow Articles by Seya, T.
The Journal of Immunology, 2006, 177: 8676-8683.
Copyright © 2006 by The American Association of Immunologists, Inc.

NAK-Associated Protein 1 Participates in Both the TLR3 and the Cytoplasmic Pathways in Type I IFN Induction1

Miwa Sasai*,{dagger}, Masashi Shingai*, Kenji Funami*, Mitsutoshi Yoneyama{ddagger}, Takashi Fujita{ddagger}, Misako Matsumoto*,{dagger},§ and Tsukasa Seya2,*,§

* Department of Microbiology and Immunology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan; {dagger} Department of Molecular Immunology, Nara Institute for Science and Technology, Ikoma, Nara, Japan; {ddagger} Department of Molecular Genetics, Institute for Virus Research, Kyoto University, Kyoto, Japan; and § Department of Immunology, Osaka Medical Center for Cancer, Higashinari-ku, Osaka, Japan

TLR3 and the cytoplasmic helicase family proteins (retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5)) serve as dsRNA pattern-recognition receptors. In response to poly(I:C), a representative of dsRNA, and viral infection, they have been shown to activate the transcription factor IFN regulatory factor (IRF)-3, which in turn induces activation of the IFN-beta promoter. RIG-I/MDA5 recognizes dsRNA in the cytoplasm, whereas TLR3 resides in the cell surface membrane or endosomes to engage in extracytoplasmic recognition of dsRNA. Recent reports suggest that TLR3 induces cellular responses in epithelial cells in response to respiratory syncytial virus (RSV). The modus for TLR3 activation by RSV, however, remains unresolved. By small interference RNA gene-silencing technology and human cell transfectants, we have revealed that knockdown of NAK-associated protein 1 (NAP1) leads to the down-regulation of IFN-beta promoter activation >24 h after poly(I:C) or virus (RSV and vesicular stomatitis virus) treatment. NAP1 is located downstream of the adapter Toll-IL-1R homology domain-containing adapter molecule (TICAM)-1 (Toll/IL-1R domain-containing adapter-inducing IFN-beta) in the TLR3 pathway, but TICAM-1 and TLR3 did not participate in the IRF-3 and IFN-beta promoter activation by RSV infection. Virus-mediated activation of the IFN-beta promoter was largely abrogated by the gene silencing of IFN-beta promoter stimulator-1 (mitochondria antiviral signaling (MAVS), VISA, Cardif), the adapter of the RIG-I/MDA5 dsRNA-recognition proteins. In both the TLR and virus-mediated IFN-inducing pathways, I{kappa}B kinase-related kinase {epsilon} and TANK-binding kinase 1 participated in IFN-beta induction. Thus, RSV as well as other viruses induces replication-mediated activation of the IFN-beta promoter, which is intracellularly initiated by the RIG-I/MDA5 but not the TLR3 pathway. Both the cytoplasmic and TLR3-mediated dsRNA recognition pathways converge upon NAP1 for the activation of the IRF-3 and IFN-beta promoter.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by Core Research for Engineering, Science, and Technology, Japan Science and Technology Corporation, by Grants-in-Aid from the Ministry of Education, Science, and Culture (Specified Project for Advanced Research) and the Hepatitis C Virus project in National Institutes of Health of Japan, and by the Naito Memorial Foundation, Uehara Memorial Foundation, Mitsubishi Foundation, and Osaka Community Foundation. M.Sa. is supported by fellowships from the Japanese Society for the Promotion of Science.

2 Address correspondence and reprint requests to Dr. Tsukasa Seya, Department of Microbiology and Immunology, Graduate School of Medicine, Hokkaido University, Kita-ku, Sapporo 060-8638, Japan. E-mail address: seya-tu{at}pop.med.hokudai.ac.jp

3 Abbreviations used in this paper: RIG-I, retinoic acid-inducible gene I; mDC, myeloid dendritic cell; MDA5, melanoma differentiation-associated gene 5; IRF, IFN regulatory factor; RSV, respiratory syncytial virus; TICAM-1, Toll-IL-1R homology domain-containing adapter molecule 1; TRIF, Toll/IL-1R domain-containing adapter-inducing IFN-beta; IPS-1, IFN-beta promoter stimulator 1; MAVS, mitochondria antiviral signaling; IKK{epsilon}, I{kappa}B kinase-related kinase {epsilon}; TBK1, TANK-binding kinase 1; NAP1, NAK-associated protein 1; RNAi, RNA interference; pAb, polyclonal Ab; TIRAP, Toll/IL-1R domain-containing adaptor protein; CARD, caspase activation and recruitment domain; VSV, vesicular stomatitis virus; MOI, multiplicity of infection; siRNA, small interference RNA; IRES, internal ribosome entry site; sih, small interference hairpin-loop; Q-PCR, quantitative PCR; NAP1 DN, NAP1 dominant negative.




This article has been cited by other articles:


Home page
J. Virol.Home page
S. Swedan, A. Musiyenko, and S. Barik
Respiratory Syncytial Virus Nonstructural Proteins Decrease Levels of Multiple Members of the Cellular Interferon Pathways
J. Virol., October 1, 2009; 83(19): 9682 - 9693.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Mikkelsen, S. B. Jensen, S. Chiliveru, J. Melchjorsen, I. Julkunen, M. Gaestel, J. S. C. Arthur, R. A. Flavell, S. Ghosh, and S. R. Paludan
RIG-I-mediated Activation of p38 MAPK Is Essential for Viral Induction of Interferon and Activation of Dendritic Cells: DEPENDENCE ON TRAF2 AND TAK1
J. Biol. Chem., April 17, 2009; 284(16): 10774 - 10782.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Oshiumi, M. Matsumoto, S. Hatakeyama, and T. Seya
Riplet/RNF135, a RING Finger Protein, Ubiquitinates RIG-I to Promote Interferon-{beta} Induction during the Early Phase of Viral Infection
J. Biol. Chem., January 9, 2009; 284(2): 807 - 817.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Tamassia, V. Le Moigne, M. Rossato, M. Donini, S. McCartney, F. Calzetti, M. Colonna, F. Bazzoni, and M. A. Cassatella
Activation of an Immunoregulatory and Antiviral Gene Expression Program in Poly(I:C)-Transfected Human Neutrophils
J. Immunol., November 1, 2008; 181(9): 6563 - 6573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Matsuo, H. Oshiumi, T. Tsujita, H. Mitani, H. Kasai, M. Yoshimizu, M. Matsumoto, and T. Seya
Teleost TLR22 Recognizes RNA Duplex to Induce IFN and Protect Cells from Birnaviruses
J. Immunol., September 1, 2008; 181(5): 3474 - 3485.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Shingai, M. Azuma, T. Ebihara, M. Sasai, K. Funami, M. Ayata, H. Ogura, H. Tsutsumi, M. Matsumoto, and T. Seya
Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction
Int. Immunol., September 1, 2008; 20(9): 1169 - 1180.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Funami, M. Sasai, H. Oshiumi, T. Seya, and M. Matsumoto
Homo-oligomerization Is Essential for Toll/Interleukin-1 Receptor Domain-containing Adaptor Molecule-1-mediated NF-{kappa}B and Interferon Regulatory Factor-3 Activation
J. Biol. Chem., June 27, 2008; 283(26): 18283 - 18291.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Zhang, Y. K. Chan, B. Lu, M. S. Diamond, and R. S. Klein
CXCR3 Mediates Region-Specific Antiviral T Cell Trafficking within the Central Nervous System during West Nile Virus Encephalitis
J. Immunol., February 15, 2008; 180(4): 2641 - 2649.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
R. E. Randall and S. Goodbourn
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
J. Gen. Virol., January 1, 2008; 89(1): 1 - 47.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Shingai, T. Ebihara, N. A. Begum, A. Kato, T. Honma, K. Matsumoto, H. Saito, H. Ogura, M. Matsumoto, and T. Seya
Differential Type I IFN-Inducing Abilities of Wild-Type versus Vaccine Strains of Measles Virus
J. Immunol., November 1, 2007; 179(9): 6123 - 6133.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Matsumiya, S. M. Prescott, and D. M. Stafforini
IFN-{epsilon} Mediates TNF-{alpha}-Induced STAT1 Phosphorylation and Induction of Retinoic Acid-Inducible Gene-I in Human Cervical Cancer Cells
J. Immunol., October 1, 2007; 179(7): 4542 - 4549.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Ebihara, H. Masuda, T. Akazawa, M. Shingai, H. Kikuta, T. Ariga, M. Matsumoto, and T. Seya
Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection
Int. Immunol., October 1, 2007; 19(10): 1145 - 1155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.